Editas Medicine Inc
(NAS:EDIT)
$
5.11
0.07 (1.39%)
Market Cap: 420.24 Mil
Enterprise Value: 158.20 Mil
PE Ratio: 0
PB Ratio: 1.43
GF Score: 52/100 - Q1 2024 Editas Medicine Inc Earnings Call TranscriptMay 08, 2024$5.04 (-11.36%)Earnings
- Q4 2023 Editas Medicine Inc Earnings Call TranscriptFeb 28, 2024$11.07 (+24.94%)Earnings
- Editas Medicine Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- Q3 2023 Editas Medicine Inc Earnings Call TranscriptNov 03, 2023$8.31 (+18.21%)Earnings
- Editas Medicine Inc at JPMorgan Biotech Fireside Investor Series TranscriptOct 12, 2023
- Editas Medicine Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 11, 2023
- Editas Medicine Inc at Wells Fargo Healthcare Conference TranscriptSep 07, 2023
- Q2 2023 Editas Medicine Inc Earnings Call TranscriptAug 02, 2023$9.14 (+5.66%)Earnings
- Editas Medicine Inc RUBY trial of EDIT-301 TranscriptJun 12, 2023
- Editas Medicine Inc at Bank of America Global Healthcare Conference TranscriptMay 10, 2023
- Q1 2023 Editas Medicine Inc Earnings Call TranscriptMay 05, 2023$9.77 (+12.04%)Earnings
- Q4 2022 Editas Medicine Inc Earnings Call TranscriptFeb 22, 2023$9.75 (+6.21%)Earnings
- Editas Medicine Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- Editas Medicine Inc EDIT-301 Clinical Update TranscriptDec 06, 2022
- Editas Medicine Inc Announces EDIT-101 Clinical Update Presentation TranscriptNov 17, 2022
- Q3 2022 Editas Medicine Inc Earnings Call TranscriptNov 02, 2022$12.89 (+1.10%)Earnings
- Editas Medicine Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2022
- Q2 2022 Editas Medicine Inc Earnings Call TranscriptAug 03, 2022$18.69 (+13.41%)Earnings
- Q1 2022 Editas Medicine Inc Earnings Call TranscriptMay 04, 2022$15.81 (+11.50%)Earnings
- Q4 2021 Editas Medicine Inc Earnings Call TranscriptFeb 24, 2022$15.86 (+10.06%)Earnings
- Editas Medicine Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2022
- Editas Medicine Inc at Barclays Gene Editing & Gene Therapy Summit (Virtual) TranscriptNov 15, 2021
- Q3 2021 Editas Medicine Inc Earnings Call TranscriptNov 08, 2021$40.57 (+8.19%)Earnings
- Editas Medicine Inc EDIT-101 Clinical Data Review Call TranscriptSep 29, 2021
- Editas Medicine Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2021
- Q2 2021 Editas Medicine Inc Earnings Call TranscriptAug 04, 2021$46.05 (+9.36%)Earnings
- Editas Medicine Inc Annual Shareholders Meeting TranscriptJun 03, 2021
- Q1 2021 Editas Medicine Inc Earnings Call TranscriptMay 05, 2021$34.72 (+0.17%)Earnings
- Editas Medicine Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 10, 2021
- Q4 2020 Editas Medicine Inc Earnings Call TranscriptFeb 25, 2021$44.76 (-9.94%)Earnings
- Editas Medicine Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 13, 2021
- Editas Medicine Inc at Barclays Virtual Gene Editing & Gene Therapy Summit TranscriptNov 16, 2020
- Q3 2020 Editas Medicine Inc Earnings Call TranscriptNov 05, 2020$31.55 (+3.61%)Earnings
- Editas Medicine Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 15, 2020
- Q2 2020 Editas Medicine Inc Earnings Call TranscriptAug 06, 2020$36.84 (+13.39%)Earnings
- Editas Medicine Inc Annual Shareholders Meeting TranscriptJun 10, 2020
- Q1 2020 Editas Medicine Inc Earnings Call TranscriptMay 07, 2020$24.1 (-3.64%)Earnings
- Q4 2019 Editas Medicine Inc Earnings Call TranscriptFeb 26, 2020$22.41 (-0.31%)Earnings
- Editas Medicine Inc at JPMorgan Healthcare Conference TranscriptJan 15, 2020
- Q3 2019 Editas Medicine Inc Earnings Call TranscriptNov 12, 2019$22.32 (+9.47%)Earnings
- Editas Medicine Inc at Morgan Stanley Healthcare Conference TranscriptSep 09, 2019
- Editas Medicine Inc, Apellis Pharmaceuticals Inc and Rigel Pharmaceuticals Inc at Citi Biotech Conference TranscriptSep 05, 2019
- Q2 2019 Editas Medicine Inc Earnings Call TranscriptAug 06, 2019$24.63 (+2.93%)Earnings
- Q1 2019 Editas Medicine Inc Earnings Call TranscriptMay 07, 2019$24.68 (-4.56%)Earnings
- Editas Medicine Inc at Barclays Global Healthcare Conference TranscriptMar 14, 2019
- Q4 2018 Editas Medicine Inc Earnings Call TranscriptFeb 28, 2019$20.63 (-1.53%)Earnings
Editas Medicine Inc Announces EDIT-101 Clinical Update Presentation Transcript
Nov 17, 2022 / 01:00PM GMT
Release Date Price:
$11.01
(-10.12%)
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)